已关闭
  • 顶部Banner位
  • 固定模块
设置
BPD
试用
AI
企业管理端
厂家
NebuSelect™ Recombinant Human LILRA1/CD85i/LIR-6, Avi-His-tag
收藏 收藏
分享
需招商
Recombinant Human LILRA1/CD85i/LIR-6, Avi-His-tag
原料试剂 研发实验室
价格
询价
品牌 辰辉创聚生物/Nebulabio
地区 中国,北京,北京市
货号 NBL-242355
产地 国产
选择规格
100ug
1mg
易享客服
辰辉创聚生物
北京辰辉创聚生物技术有限公司
中国北京
营业执照已审核
致力于为全球生物医药客户提供高品质原料。辰辉创聚生物依托深厚的蛋白质、免疫学及生物化学技术基础,深入研发并不断拓展,形成了以蛋白质现货、ELISA现货、诊断原料现货为主的丰富产品体系。
进入店铺
产品规格 图文详情 技术文档
产品规格
品牌名称
辰辉创聚生物/Nebulabio
货号
NBL-242355
国产/进口
国产
规格
100ug,1mg
储存条件
Store at 4°C for short-term, -20°C for long-term. Avoid repeated freezing and thawing cycles.
货源
新品
图文详情

Description:NebuSelect™ Recombinant Human LILRA1/CD85i/LIR-6, Avi-His-tag(Cat#NBL-242355) is expressed in HEK293 with His tag and Avi tag at the C-Terminus.It contains Pro17-Asn461.

Species:Human

Expression System:HEK293

Molecular Weight: The protein has a predicted MW of 51.4 kDa. Due to glycosylation, the protein migrates to 70-80 kDa based on Bis-Tris PAGE result.

Target Name:LILRA1/CD85i/LIR-6SynonymsCD85i; LILRA1; LIR6; LIR-6; LIR6MGC126563

Target Information:LILRA1, also known as CD85i and LIR-6, is an approximately 70 kDa variably glycosylated transmembrane protein that regulates immune cell activation. Mature human LILRA1 consists of a 445 amino acid (aa) extracellular domain (ECD) with 4 Ig-like domains, a 21 aa transmembrane segment, and a 7 aa cytoplasmic tail. LILRA1 may act as receptor for class I MHC antigens.

Amino Acid Sequence: Pro17-Asn461

Purity:>95%

Endotoxin:<1EU/ug(LAL Method)

技术文档
没有您想要的资料?去索要
返回顶部